Mixtures

Physiologically Based Pharmacokinetic Modeling: Science and Applications

Volumn , Issue , 2005, Pages 349-373

  Yang, Raymond S H ^a   Andersen, Melvin E ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

Competitive enzyme inhibition.; Gene network modeling.; Hybrid PBPK reaction network modeling; Mechanism based inhibition.; PBPK modeling of mixtures.; Reaction network modeling.; Simple and complex mixtures.; Toxicological interactions.

Indexed keywords

EID: 84886523512     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471478768.ch13     Document Type: Chapter

References (62)

1. Ali, N., and Tardif, R. (1999). Toxicokinetic modeling of the combined exposure of toluene and n-hexane in rats and humans. J. Occup. Health 41, 95-103.
2. Andersen, M. E., and Clewell, H. J. (1984). Pharmacokinetic interactions of mixtures. In: Proceedings of the 14th Conference on Environmental Toxicology, AFAMRL-TR-83-099, Air Force Aerospace Medical Research Laboratory, Wright-Patterson AFB, OH, pp. 226-238.
3. Andersen, M. E., Gargas, M. L., Clewell, H. J., III, and Severyn, K. M. (1987). Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharmacol. 89, 149-157.
4. Andersen, M. E., Yang, R. S. H., French, C. T., Chubb, L. S., and Dennison, J. E. (2002). Molecular circuits, biological switches and non-linear dose-response relationships. Environ. Health Perspect. 110(Suppl 6), 971-978.
5. Barton, H. A., Creech, J. R., Godin, C. S., Randall, G. M., and Seckel, C. S. (1995). Chloroethylene mixtures: Pharmacokinetic modeling and in vitro metabolism of vinyl chloride, trichloroethylene, and trans-1,2-dichloroethylene in rats. Toxicol. Appl. Pharmacol. 130, 237-247.
6. Bond, J. A., Csanady, G. A., Gargas, M. L., Guengerich, F. P., Leavens, T., Medinsky, M. A., and Recio, L. (1994). 1,3-Butadiene: linking metabolism, dosimetry, and mutation induction. Environ. Health Perspect. 102(Suppl 9), 87-94.
7. Butler, D. (1999). Computing 2010 from black holes to biology. Nature 402, C67-C70.
8. Clewell, H. J., III, and Andersen, M. E. (1985). Risk assessment extrapolations and physiological modeling. Toxicol. Ind. Health 1, 111-131.
9. Dennison, J. E. 2004. Physiologically-Based Pharmacokinetic Modeling of Simple and Complex Mixtures of Gasoline and the Gasoline Components n-Hexane, Benzene, Toluene, Ethylbenzene, and Xylene. Ph.D. dissertation, Colorado State University, 218 pp.
10. Dennison, J. E., Andersen, M. E., and Yang, R. S. H. (2003). Characterization of the pharmacokinetics of gasoline using PBPK modeling with a complex mixture chemical lumping approach. Inhalation Toxicol. 15, 961-968.
11. Dennison, J. E., Andersen, M. E., Dobrev, I. D., Mumtaz, M. M., and Yang, R. S. H. (2004a). PBPK modeling of complex hydrocarbon mixtures: Gasoline. Environ. Toxicol. Pharmacol. 16: 107-119.
12. Dennison, J. E., Andersen, M. E., Clewell, H. J., and Yang, R. S. H. (2004b). Development of a PBPK model for volatile fractions of gasoline using chemical lumping analyses. Environ. Sci. Tech. 38: 5674-5681.
13. Dennison, J. E., Bigelow, P. L., Mumtaz, M. M., Andersen, M. E., Dobrev, I. D., and Yang, R. S. H. (2005a). Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylenes): A PBPK modeling approach. Am. Ind. Hyg. Assoc. J. In press.
14. Dennison, J. E., Andersen, M. E., and Yang, R. S. H. (2005b). Pitfalls and related improvements of in vivo gas uptake pharmacokinetic experimental systems. Submitted for publication.
15. Dobrev, I., Andersen, M. E., and Yang, R. S. H. (2001). Assessing interaction thresholds for trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling. Arch. Toxicol. 75, 134-144.
16. Dobrev, I., Andersen, M. E., and Yang, R. S. H. (2002). In silico toxicology: Simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1- trichloroethane. Environ. Health Perspect. 110, 1031-1039.
17. D'Souza, R. W., Francis, W. R., and Andersen, M. E. (1988). Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. J. Pharmacol. Exp. Ther. 245, 563-568.
18. El-Masri, H. A., Thomas, R. S., Sabados, G. R., Phillips, J. K., Constan, A. A., Benjamin, S. A., Andersen, M. E., Mehendale, H. M., and Yang, R. S. H. (1996a). Physiologically based pharmacokinetic/ pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone. Arch. Toxicol. 70, 704-713.
19. El-Masri, H. A., Tessari, J. D., and Yang, R. S. H. (1996b). Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethylene: Utilization of a PBPK model. Arch. Toxicol. 70, 527-539.
20. El-Masri, H. A., Constan, A. A., Ramsdell, H. S., and Yang, R. S. H. (1996c). Physiologically based pharmacodynamic modeling of an interaction threshold between trichloroethylene and 1,1- dichloroethylene in Fischer 344 rats. Toxicol. Appl. Pharmacol. 141, 124-132.
21. Filser, J. G., Johanson, G., Kessler, W., Kreuzer, P. E., Stei, P., Baur, C., and Csanady, G. A. (1993). A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure. IARC Sci Publ. 127, 65-78.
22. Frederick, C. B., Potter, D. W., Chang-Mateu, M. I., and Andersen, M. E. (1992). A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. Toxicol. Appl. Pharmacol. 114, 246-260.
23. Gargas, M. L., Andersen, M. E., and Clewell, H. J., III. (1986). A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol. Appl. Pharmacol. 86, 341-352.
24. Haddad, S., Tardif, R., Viau, C., and Krishnan, K. (1999a). A modeling approach to account for toxicokinetic interactions in the calculation of biological hazard index for chemical mixtures. Toxicol Lett. 108, 303-308.
25. Haddad, S., Tardif, R., Charest-Tardif, G., and Krishnan, K. (1999b). Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 161, 249-257.
26. Haddad, S., Charest-Tardif, G., Tardif, R., and Krishnan, K. (2000). Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures. Toxicol. Appl. Pharmacol. 167, 199-209.
27. Ito, K., Iwatsubo, T., Kanamitsu, S., Ueda, K., Suzuki, H., and Sugiyama, Y. (1998). Prediction of pharmacokinetic alterations caused by drug-drug interactions: Metabolic interaction in the liver. Pharmacol Rev. 50, 387-412.
28. Jang, J. Y., Droz, P. O., and Kim, S. (2001). Biological monitoring of workers exposed to ethylbenzene and co-exposed to xylene. Int. Arch. Occup. Environ. Health 74, 31-37.
29. Kanamitsu, S., Ito, K., Green, C. E., Tyson, C. A., Shimada, N., and Sugiyama, Y. (2000). Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4. Pharm Res. 17, 419-426.
30. Klein, M. T., Hou, G., Quann, R., Wei, W., Liao, K. H., Yang, R. S. H., Campain, J. A., Mazurek, M., and Broadbelt, L. J. (2002). BioMOL: A computer-assisted biological modeling tool for complex chemical mixtures and biological processes at the molecular level. Environ. Health Perspect. 110(Suppl 6), 1025-1029.
31. Krishnan, K., Andersen, M. E., Clewell, H. J., III, and Yang, R. S. H. (1994a). Physiologically Based Pharmacokinetic Modeling of Chemical Mixtures. In Toxicology of Chemical Mixtures: Case Studies, Mechanisms, and Novel Approaches, R. S. H. Yang, ed., Academic Press, San Diego, CA, pp. 399-437.
32. Krishnan, K., Clewell, H. J., III, and Andersen, M. E. (1994b). Physiologically-based pharmacokinetic analyses of simple mixtures. Environ. Health Perspect. 102(Suppl 9), 151-155.
33. Krishnan, K., Haddad, S., Beliveau, M., and Tardif, R. (2002). Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures. Environ. Health Perspect. 110(Suppl 6), 989-994.
34. Krishnan, K., and Pelekis, M. (1995). Hematotoxic interactions: Occurrence, mechanisms and predictability. Toxicology 105, 355-364.
35. Leavens, T. L., and Bond, J. A. (1996). Pharmacokinetic model describing the disposition of butadiene and styrene in mice. Toxicology 113, 310-313.
36. Liao, K. H. (2004). Reaction Network Model for the Prediction of Mammalian Metabolism of Benzo[a]pyrene. Ph.D. dissertation, Colorado State University
37. Liao, K. H., Dobrev, I., Dennison, Jr., J. E., Andersen, M. E., Reisfeld, B., Reardon, K. F., Campain, J. A., Wei, W., Klein, M. T., Quann, R. J., and Yang, R. S. H. (2002). Application of biologically based computer modeling to simple or complex mixtures. Environ. Health Perspect. 110(Suppl 6), 957-963.
38. Lilly, P. D., Thornton-Manning, J. R., Gargas, M. L., Clewell, H. J., and Andersen, M. E. (1998). Kinetic characterization of CYP2E1 inhibition in vivo and in vitro by the chloroethylenes. Arch Toxicol. 72, 609-621.
39. Mehendale, H. M. (1984). Potentiation of halomethane hepatotoxicity: Chlordecone and carbon tetrachloride. Fundam. Appl. Toxicol. 4, 295-308.
40. Mehendale, H. M. (1991). Role of hepatocellular regeneration and hepatolubular healing in the final outcome of liver injury. Biochem. Pharmacol. 42, 1155-1162.
41. Mehendale, H. M. (1994). Mechanism of the interactive amplification of halomethane hepatotoxicity and lethality by other chemicals. In: Yang, R. S. H., ed., Toxicology of Chemical Mixtures: Case Studies, Mechanisms, and Novel Approaches, Academic Press, San Diego, CA, pp. 299-334.
42. Mozayani, A., and Raymon, L. P. (2004). Handbook of Drug Interactions. A Clinical and Forensic Guide, Humana Press, Totowa, NJ, 663 pp.
43. Mumtaz, M. M., Sipes, I. G., Clewell, H. J., and Yang, R. S. H. (1993). Risk assessment of chemical mixtures: Biologic and toxicologic issues. Fundam. Appl. Toxicol. 21, 258-269.
44. Ogata, M., Fiserova-Bergerova, V., and Droz, P. O. (1993). Occupational exposures to mixtures of industrial chemicals. Appl. Occup. Environ. Hyg. 8, 609-617.
45. Pelekis, M., and Krishnan, K. (1997). Assessing the relevance of rodent data on chemical interactions for health risk assessment purposes: A case study with dichloromethane-toluene mixture. Regul. Toxicol. Pharmacol. 25, 79-86.
46. Purcell, K. J., Cason, G. H., Gargas, M. L., Andersen, M. E., and Travis, C. C. (1990). In vivo metabolic interactions of benzene and toluene. Toxicol. Lett. 52, 141-152.
47. Ramsey, J. C., and Andersen, M. E. (1984). A physiological model for the inhalation pharmacokinetics of inhaled styrene monomer in rats and humans. Toxicol. Appl. Pharmacol. 73, 159-175.
48. Reisfeld, B., and Yang, R. S. H. (2004). A reaction network model for CYP2E1-mediated metabolism of toxicant mixtures. Environ. Toxicol. Pharmacol. 18, 173-179.
49. Sato, A., and Nakajima, T. (1979). A vial-equilibration method to evaluate the drug-metabolizing enzyme activity for volatile hydrocarbons. Toxicol. Appl. Pharmacol. 47, 41-46.
50. Sato, A., Endoh, K., Kaneko, T., and Johanson, G. (1991). Effects of consumption of ethanol on the biological monitoring of exposure to organic solvent vapor: A simulation study with trichloroethylene. Brit. J. Ind. Med. 48, 548-556.
51. Segal, I. H. (1975). Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, John Wiley & Sons, New York, 957 pp.
52. Tardif, R., and Charest-Tardif, G. (1999). The importance of measured end-points in demonstrating the occurrence of interactions: a case study with methylchloroform and m-xylene. Toxicol. Sci. 49, 312-317.
53. Tardif, R., Lapare, S., Krishnan, K., and Brodeur, J. (1993). A descriptive and mechanistic study of the interaction between toluene and xylene in humans. Int. Arch. Occup. Environ. Health 65(1 Suppl), S135-S137.
54. Tardif, R., Lapare, S., Charest-Tardif, G., Brodeur, J., and Krishnan, K. (1995). Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans. Risk Anal. 15, 335-342.
55. Tardif, R., Lapare, S., Charest-Tardif, G., Brodeur, J., and Krishnan, K. (1997). Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol. Appl. Pharmacol. 144, 120-134.
56. Thakore, K. N., Gargas, M. L., Andersen, M. E., and Mehendale, H. M. (1991). PBPK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, Phenobarbital or mirex. Toxicol. Appl. Toxicol. 109, 514-528.
57. Thrall, K. D., and Poet, T. S. (2000). Determination of biokinetic interactions in chemical mixtures using real-time breath analysis and physiologically based pharmacokinetic modeling. J. Toxicol. Environ. Health A. 59, 653-670.
58. US EPA. (2003). Physiologically-based Pharmacokinetic/Pharmacodynamic Modeling: Preliminary Evaluation and Case Study for the N-Methyl Carbamate Pesticides: A Consultation, December 11 and 12, 2003 FIFRA Scientific Advisory Panel Meeting, Arlington, Virginia, SAP Minutes No. 2003-06 (http://www.epa.gov/oscpmont/sap/2003/index.htm#121103; accessed March 28, 2004)
59. Verhaar, H. J. M., Morroni, J. S., Reardon, K. F., Hays, S. M., Gaver, D. P., Carpenter, R. L., and Yang, R. S. H. (1997). A proposed approach to study the toxicology of complex mixtures of petroleum products: The integrated use of QSAR, lumping analysis, and PBPK/PD modeling. Environ. Health Perspect. 105(Suppl 1), 179-195.
60. Yang, R. S. H., Andersen, M. E., Dennison, J. E., Ou, Y. C., Liao, K. H., and Reisfeld, B. (2004a). Physiologically based pharmacokinetic and pharmacodynamic modeling, in Mouse Models of Cancer, E. C. Holland, ed., John Wiley & Sons, New York, pp. 391-405.
61. Yang, R. S. H., El-Masri, H. A., Thomas, R. S., Dobrev, I., Dennison, Jr., J. E., Bae, D. S., Campain, J. A., Liao, K. H., Reisfeld, B., Andersen, M. E., and Mumtaz, M. M. (2004b). Chemical mixture toxicology: From descriptive to mechanistic, and going on to in silico toxicology. Environ. Toxicol. Pharmacol. 18, 65-81.
62. Yu, X., Johanson, G., Ichihara, G., Shibata, E., Kamijima, M., Ono, Y., and Takeuchi, Y. (1998). Physiologically based pharmacokinetic modeling of metabolic interactions between n-hexane and toluene in humans. J. Occup. Health 40, 293-301.